Evercore Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price

Danaher (NYSE:DHR) had its price objective cut by research analysts at Evercore from $254.00 to $225.00 in a report issued on Monday,MarketScreener reports. The brokerage currently has an “outperform” rating on the conglomerate’s stock. Evercore’s target price suggests a potential upside of 17.78% from the stock’s current price.

Other research analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Leerink Partners upped their price target on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Finally, Argus set a $265.00 price target on Danaher in a report on Wednesday, January 14th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $253.79.

Danaher Price Performance

NYSE DHR opened at $191.03 on Monday. The stock has a market capitalization of $135.19 billion, a P/E ratio of 37.90, a P/E/G ratio of 2.59 and a beta of 0.95. Danaher has a 1 year low of $171.00 and a 1 year high of $242.80. The business’s fifty day moving average is $202.70 and its two-hundred day moving average is $214.59. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.14 earnings per share. On average, research analysts forecast that Danaher will post 7.63 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.20% of the company’s stock.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sivia Capital Partners LLC grew its holdings in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares in the last quarter. First Trust Advisors LP grew its holdings in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares in the last quarter. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Danaher by 8.9% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 1,792 shares of the conglomerate’s stock valued at $354,000 after acquiring an additional 146 shares in the last quarter. Gabelli Funds LLC grew its holdings in shares of Danaher by 3.9% during the 2nd quarter. Gabelli Funds LLC now owns 18,931 shares of the conglomerate’s stock valued at $3,740,000 after acquiring an additional 706 shares in the last quarter. Finally, Cerity Partners LLC grew its holdings in shares of Danaher by 1.6% during the 2nd quarter. Cerity Partners LLC now owns 342,876 shares of the conglomerate’s stock valued at $67,733,000 after acquiring an additional 5,467 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.